These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 156637)

  • 1. Monoaminergic control of episodic growth hormone secretion in the rat: effects of reserpine, alpha-methyl-p-tyrosine, p-chlorophenylalanine, and haloperidol.
    Edén S; Bolle P; Modigh K
    Endocrinology; 1979 Aug; 105(2):523-9. PubMed ID: 156637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of norepinephrine alpha 2-receptor activation for morphine-induced rat growth hormone secretion.
    Eriksson E; Edén S; Modigh K
    Neuroendocrinology; 1981 Aug; 33(2):91-6. PubMed ID: 6267499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of reserpine, alpha-methyl-p-tyrosine, p-chlorophenylalanine and 5,7-dihydroxytryptamine on the hippocampal kindling effect in rats.
    Araki H; Aihara H; Watanabe S; Yamamoto T; Ueki S
    Jpn J Pharmacol; 1983 Dec; 33(6):1177-82. PubMed ID: 6230476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a role of alpha-adrenergic mechanisms in regulation of episodic growth hormone secretion in the rat.
    Durand D; Martin JB; Brazeau P
    Endocrinology; 1977 Mar; 100(3):722-8. PubMed ID: 233821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilocarpine-induced purposeless chewing behaviour in rats is dependent on intact central stores of 5-HT.
    Stewart B; Rose S; Jenner P; Marsden CD
    Eur J Pharmacol; 1987 Oct; 142(1):173-6. PubMed ID: 2961579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of drugs interfering with biogenic amines metabolism on gastric secretion and reserpine-ulcers development in rats.
    Hano J; Bugajski J; Wantuch C
    Pol J Pharmacol Pharm; 1978; 30(4):501-11. PubMed ID: 740552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catecholaminergic regulation of opiate-stimulated growth hormone secretion in the developing rat.
    Bero LA; Kuhn CM
    J Pharmacol Exp Ther; 1986 Apr; 237(1):137-42. PubMed ID: 3007734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biogenic amines and narcotic effects. I. Modification of morphine-induced analgesia and motor activity after alteration of cerebral amine levels.
    Buxbaum DM; Yarbrough GG; Carter ME
    J Pharmacol Exp Ther; 1973 May; 185(2):317-27. PubMed ID: 4267383
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of brain amines in the fetal hyperpyrexia caused by tranylcypromine in LiCl-pretreated rats.
    Shimomura K; Hashimoto M; Mori J; Honda F
    Jpn J Pharmacol; 1979 Apr; 29(2):161-70. PubMed ID: 161335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of biogenic amines in the reserpine-induced alteration of minimal electroshock seizure thresholds in the mouse.
    Wenger GR; Stitzel RE; Craig CR
    Neuropharmacology; 1973 Jul; 12(7):693-703. PubMed ID: 4147164
    [No Abstract]   [Full Text] [Related]  

  • 11. Involvement of brain monoamines in the stimulant and paradoxical inhibitory effects of methylphenidate.
    Breese GR; Cooper BR; Hollister AS
    Psychopharmacologia; 1975 Oct; 44(1):5-10. PubMed ID: 128026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mode of action of morphine on a quickly learned conditioned suppression in mice.
    Kameyama T; Nagasaka M
    J Pharmacobiodyn; 1984 Mar; 7(3):151-5. PubMed ID: 6235360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin mediated inhibition of episodic luteinizing hormone release during electrical stimulation of the arcuate nucleus in ovariectomized rats.
    Gallo RV; Moberg GP
    Endocrinology; 1977 Apr; 100(4):945-54. PubMed ID: 138587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reserpine and the monoaminergic regulation of adrenal dopamine beta-hydroxylase activity.
    Lima L; Sourkes TL
    Neuroscience; 1986; 17(1):235-45. PubMed ID: 2938024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic stimulation of pituitary but not hypothalamic estrogen receptors in ovariectomized rats.
    Carrillo AJ; Steger RW; Chamness GC
    Endocrinology; 1983 May; 112(5):1839-46. PubMed ID: 6131816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of palmatine on motor activity and the concentration of central monoamines and its metabolites in rats.
    Hsieh MT; Su SH; Tsai HY; Peng WH; Hsieh CC; Chen CF
    Jpn J Pharmacol; 1993 Jan; 61(1):1-5. PubMed ID: 7679763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the role of central nervous system catecholamines and 5-hydroxytryptamine in the nialamide-induced behavioural syndrome.
    Modigh K; Svensson TH
    Br J Pharmacol; 1972 Sep; 46(1):32-45. PubMed ID: 4263796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological analysis of the neurotransmitter mechanisms regulating phenylethanolamine N-methyltransferase in the adrenal gland.
    Lima L; Sourkes TL
    Biochem Pharmacol; 1986 Nov; 35(22):3965-9. PubMed ID: 2946301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between norepinephrine and serotonin in the neuroendocrine control of growth hormone release in the rat.
    Conway S; Richardson L; Speciale S; Moherek R; Mauceri H; Krulich L
    Endocrinology; 1990 Feb; 126(2):1022-30. PubMed ID: 1688789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamines and the mechanisms of action of antitussive drugs in rats.
    Kamei J; Ogawa M; Kasuya Y
    Arch Int Pharmacodyn Ther; 1987 Nov; 290(1):117-27. PubMed ID: 2965557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.